Skip to main content
OpenTrials
Completed

NCT Number: NCT07548541

Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic and Cognitive Performance in Recreationally Active Males

This randomized, double-blind, four-period crossover trial investigates the acute effects of creatine monohydrate, L-arginine, and their combined administration on anaerobic performance, jump performance, and cognitive reaction time in recreationally active adult males. Eighteen healthy male participants complete four experimental conditions in randomized order: placebo, creatine, L-arginine, and creatine plus L-arginine, with at least 72 hours between sessions. Sixty minutes after supplementation, participants perform the Stroop Color-Word Test, countermovement jump test, and Running-Based Anaerobic Sprint Test. Primary outcomes include peak power, average power, countermovement jump height, and incongruent Stroop reaction time. The study aims to determine whether acute co-supplementation produces greater ergogenic and cognitive benefits than either supplement alone or placebo.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Inonu University, Faculty of Sport Sciences

Malatya, 44280, Turkey (Türkiye)

About this study

Creatine monohydrate and L-arginine are widely used ergogenic supplements that may influence performance through different physiological mechanisms. Creatine contributes to rapid adenosine triphosphate resynthesis through phosphocreatine availability, whereas L-arginine serves as a precursor for nitric oxide synthesis and may enhance blood flow and substrate delivery during exercise. Their combined administration may therefore produce complementary effects on physical and cognitive performance.

This study uses a randomized, double-blind, four-treatment crossover design in recreationally active adult males. Each participant completes four conditions: placebo, creatine monohydrate, L-arginine, and combined creatine plus L-arginine. Sessions are separated by at least 72 hours, and all testing is conducted at the same time of day. Supplementation is administered 60 minutes before performance testing. Creatine is provided as a single acute dose of 0.3 g/kg, L-arginine as 6 g, and the placebo as a matched control beverage.

Outcome assessments include the Running-Based Anaerobic Sprint Test for repeated-sprint power, the countermovement jump test for explosive lower-body performance, and the Stroop Color-Word Test for cognitive reaction time and accuracy. The primary objective is to examine whether acute co-supplementation with creatine and L-arginine improves anaerobic and cognitive outcomes more than placebo or either supplement alone.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male recreational athletes aged 18 years or older
  • At least 2 years of regular participation in organized sport
  • Apparently healthy and able to complete high-intensity exercise testing

Exclusion criteria

  • Known orthopedic, neurological, cardiovascular, pulmonary, or metabolic disorders
  • Use of anabolic steroids or performance-enhancing drugs within the previous 3 months
  • Use of psychoactive or stimulant substances during the study

Treatment and study plan

Creatine Monohydrate

Dietary Supplement

Acute oral creatine monohydrate supplementation at 0.3 g/kg body mass.

L-Arginine

Dietary Supplement

Acute oral L-arginine supplementation at a dose of 6 g.

Placebo

Other

Placebo beverage containing 6 g sucrose dissolved in 250 mL of water.

Primary outcomes

  1. RAST Average Power

    Time frame: 60 minutes after supplementation, during the testing session

    Average power during the Running-Based Anaerobic Sprint Test following acute supplementation.

  2. RAST Peak Power

    Time frame: 60 minutes after supplementation, during the testing session

    Peak power during the Running-Based Anaerobic Sprint Test following acute supplementation.

  3. Countermovement Jump Height

    Time frame: 60 minutes after supplementation, during the testing session

    Best countermovement jump height measured using the Optojump system following acute supplementation.

  4. Stroop Incongruent Median Reaction Time

    Time frame: 60 minutes after supplementation, during the testing session

    Median reaction time in the incongruent condition of the computerized Stroop Color-Word Test following acute supplementation.

Secondary outcomes

  1. RAST Minimum Power

    Time frame: 60 minutes after supplementation, during the testing session

    Minimum power during the Running-Based Anaerobic Sprint Test following acute supplementation.

  2. RAST Fatigue Index

    Time frame: 60 minutes after supplementation, during the testing session

    Fatigue index during the Running-Based Anaerobic Sprint Test following acute supplementation.

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Collaborators

  • Princess Nourah Bint Abdulrahman University

Registry information

Official study title

Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic Power, Jump Performance, and Cognitive Reaction Time in Recreationally Active Males: A Randomized Crossover Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 23, 2026
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.